about
The effects of dietary polyphenols on reproductive health and early developmentEvaluation of the efficacy & biochemical mechanism of cell death induction by Piper longum extract selectively in in-vitro and in-vivo models of human cancer cellsChinese slimming capsules containing sibutramine sold over the Internet: a case seriesInhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats.Research on the change of chemical composition in productive process of Re Du Ning injection by HPLC/Q-TOF MS.Common use of dietary supplements for bipolar disorder: a naturalistic, self-reported study.Ethnic differences in medicinal plant use among University students: a cross-sectional survey of self-reported medicinal plant use at two Midwest Universities.Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)Evaluation of chinese-herbal-medicine-induced herb-drug interactions: focusing on organic anion transporter 1.Evaluation of antioxidant profile and activity of amalaki (Emblica officinalis), spirulina and wheat grassLC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus MerrNext revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.Quince peel polyphenolic extract blocks human colon adenocarcinoma LS174 cell growth and potentiates 5-fluorouracil efficacy.Future directions for research on Silybum marianum for cancer patients.Variable inhibitory effect of herbal supplements of different brands on human P450 CYP1A2Plant-Derived Small Molecule Inhibitors of Neuronal NO-Synthase: Potential Effects on Protein DegradationAntiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship.Herb-drug pharmacokinetic interactions reviewed.Introductory pharmacology for clinical practice.Probiotic fermentation of plant based products: possibilities and opportunities.The effect of garlic supplements and phytochemicals on the ADMET properties of drugs.Evaluation of the impact of Flos Daturae on rat hepatic cytochrome P450 enzymes by cocktail probe drugs.Angelica sinensis (Umbelliferae) with proven repellent properties against Aedes aegypti, the primary dengue fever vector in Thailand.Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways.Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4.Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products.Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats.Effects of Salvia miltiorrhiza extract on the liver CYP3A activity in humans and rats.Rapid Authentication of Ginkgo biloba Herbal Products Using the Recombinase Polymerase Amplification Assay.The Inhibition of Human Cytochrome P450 by Ethanol Extracts of North American Botanicals
P2860
Q26863346-38F81AD9-713F-4A56-8B92-399DC16C2565Q28545011-5A65558D-0E8D-451B-A24C-88363BEA50B6Q34983224-29B6E815-2AE9-4683-8357-6AFB7E54DCEDQ35108016-C929B911-41DF-455B-99F2-521F33A26D2DQ35658673-61AD9A26-E180-467E-A911-A1C7DD7B2A4BQ35671034-76E2418D-DEF8-4F14-902F-EB1EFDE5EEC5Q35671304-4B273330-83B3-4D95-9106-E1CE1EA05D5FQ35725540-06C66B4B-2621-4BB7-8D48-B10613E7914CQ36228911-AA8B7BF2-F0C8-41D6-B3A1-A84F8F1DD900Q36263884-CCEBB819-E514-4ED5-975E-8C5BE63CA8CBQ36307639-DD8D3AFB-7A58-46CA-A402-F88536762976Q36481129-BEDFBA62-9188-465E-95C7-53DBE57F230DQ36531205-3FF6E4D3-E225-4EEA-AA3C-3E55790DAB5AQ36840447-EE39E4D7-B10C-45FB-BA2E-CF7E915F07C3Q36980217-4014402D-8ECA-4801-AAB1-EFB241D8BFCDQ37079745-33AB70CE-B9F0-4BD6-9BA5-F7ADD4ED671EQ37481442-5F7BC592-0E5C-4F69-A307-146F8879A351Q37601039-C3E36DF9-2CC6-41DB-BE7B-CA5A3082A75FQ37808478-40BB1D95-E61F-4318-BB2D-531CA49F7AA9Q37871036-EB9DBA90-0FF4-4070-B8C6-C8195DB006C6Q37953487-39692700-C2DE-4AC4-85FB-69F0770507EEQ37982110-5433B85A-D861-4C4B-9BBE-133BB241039AQ39991454-230CCD38-E75A-4E54-8103-E4A4E3DF1547Q40165124-116AB447-23ED-4931-BFB7-82E55EA92D7DQ41781853-CC1C2C87-65B7-4766-83AE-B7F9B20455F6Q42956074-6533E4E1-DCF4-4C5A-9E1B-427B071361E9Q46057118-03323869-01C3-4B2B-8A8C-D13DFA21B97CQ46861103-2B11043C-BDD6-46CA-9E9E-EC8A78BCEECBQ47782012-E5832A58-BC4C-4945-B65B-55BB19969966Q48277497-695A1880-DD7B-4A4F-818B-CCBCCDE26904Q55189649-E1C9BBC0-0EB9-4BCC-ADDF-D7E3B0EA2FF3Q57778542-22CF44F8-575C-4BD6-BF84-2D1BE629836E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Natural health products and drug disposition.
@ast
Natural health products and drug disposition.
@en
type
label
Natural health products and drug disposition.
@ast
Natural health products and drug disposition.
@en
prefLabel
Natural health products and drug disposition.
@ast
Natural health products and drug disposition.
@en
P2093
P1476
Natural health products and drug disposition.
@en
P2093
Brian C Foster
Colin J Briggs
J Thor Arnason
P304
P356
10.1146/ANNUREV.PHARMTOX.45.120403.095950
P577
2005-01-01T00:00:00Z